PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Cancer 1,053,491 Disease Target Erbb2 4,536 2,833 0.04 -0.61 0.62 0.63
Cancer 1,053,491 Disease Target BRAF 4,766 2,231 0.03 -0.73 0.47 0.62
Cancer 1,053,491 Disease Target CA 15-3 898 698 0.02 -0.47 0.78 0.61
Cancer 1,053,491 Disease Target Cox-2 21,583 5,031 0.03 -0.87 0.23 0.61
Cancer 1,053,491 Disease Target EGF 27,487 5,238 0.03 -0.90 0.19 0.61
Cancer 1,053,491 Disease Target Urokinase-Type Plasminogen Activator 3,939 1,166 0.02 -0.84 0.30 0.60
Cancer 1,053,491 Disease Target ERBB3 1,154 481 0.01 -0.76 0.42 0.60
Cancer 1,053,491 Disease Target CHK2 1,391 533 0.01 -0.79 0.38 0.60
Cancer 1,053,491 Disease Target CHK1 2,044 681 0.01 -0.82 0.33 0.60
Cancer 1,053,491 Disease Target ERK1 18,374 2,955 0.02 -0.91 0.16 0.59
Cancer 1,053,491 Disease Target Insulin-Like Growth Factor 1 Receptor 1,052 405 0.01 -0.78 0.38 0.59
Cancer 1,053,491 Disease Target EPHA2 532 239 0.01 -0.74 0.45 0.59
Cancer 1,053,491 Disease Target CA 72-4 184 112 0.01 -0.63 0.61 0.59
Cancer 1,053,491 Disease Target AFP 9,751 1,749 0.02 -0.91 0.18 0.59
Cancer 1,053,491 Disease Target Aurora Kinase A 196 103 0.01 -0.69 0.53 0.59
Cancer 1,053,491 Disease Target AKT2 873 284 0.01 -0.82 0.33 0.59
Cancer 1,053,491 Disease Target Carbonic Anhydrase 9 150 80 0.01 -0.68 0.53 0.59
Cancer 1,053,491 Disease Target Multidrug Resistance Protein 1 495 183 0.01 -0.79 0.37 0.59
Cancer 1,053,491 Disease Target DAPK1 205 94 0.01 -0.74 0.46 0.58
Cancer 1,053,491 Disease Target AKT3 293 117 0.01 -0.77 0.40 0.58
Cancer 1,053,491 Disease Target Ret Proto-Oncogene 1,005 281 0.01 -0.85 0.28 0.58
Cancer 1,053,491 Disease Target ERBB4 994 273 0.01 -0.85 0.27 0.58
Cancer 1,053,491 Disease Target Hypoxia-Inducible Factor 1-Alpha 923 257 0.01 -0.85 0.28 0.58
Cancer 1,053,491 Disease Target Aurora A kinase 318 118 0.01 -0.79 0.37 0.58
Cancer 1,053,491 Disease Target APO-2L 90 44 0.00 -0.71 0.49 0.58
Cancer 1,053,491 Disease Target Cytokeratin 8 587 162 0.01 -0.85 0.28 0.58
Cancer 1,053,491 Disease Target Cytokeratin 18 1,108 249 0.01 -0.88 0.22 0.58
Cancer 1,053,491 Disease Target AXL 633 165 0.01 -0.86 0.26 0.58
Cancer 1,053,491 Disease Target Kallikrein-6 79 35 0.00 -0.75 0.44 0.58
Cancer 1,053,491 Disease Target Epiregulin 291 91 0.01 -0.83 0.31 0.58
Cancer 1,053,491 Disease Target Equilibrative Nucleoside Transporter 1 211 71 0.00 -0.81 0.34 0.58
Cancer 1,053,491 Disease Target CYR61 539 138 0.01 -0.86 0.26 0.58
Cancer 1,053,491 Disease Target Methylenetetrahydrofolate Reductase 3,573 555 0.01 -0.92 0.16 0.58
Cancer 1,053,491 Disease Target EPHB4 329 94 0.01 -0.85 0.29 0.58
Cancer 1,053,491 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 6 0.00 -0.50 0.75 0.58
Cancer 1,053,491 Disease Target Galectin-1 1,131 229 0.01 -0.89 0.20 0.57
Cancer 1,053,491 Disease Target BRK 236 70 0.00 -0.84 0.30 0.57
Cancer 1,053,491 Disease Target EPHB2 385 97 0.00 -0.86 0.25 0.57
Cancer 1,053,491 Disease Target CD34 24,598 2,119 0.01 -0.95 0.09 0.57
Cancer 1,053,491 Disease Target Kallikrein-8 19 10 0.00 -0.69 0.53 0.57
Cancer 1,053,491 Disease Target Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 3 0.00 -0.50 0.75 0.57
Cancer 1,053,491 Disease Target Endoglin 1,333 232 0.01 -0.91 0.17 0.57
Cancer 1,053,491 Disease Target CD95 4,266 541 0.01 -0.93 0.13 0.57
Cancer 1,053,491 Disease Target CD137 474 102 0.00 -0.89 0.22 0.57
Cancer 1,053,491 Disease Target Multidrug Resistance-Associated Protein 2 462 100 0.00 -0.89 0.22 0.57
Cancer 1,053,491 Disease Target Annexin A1 406 86 0.00 -0.89 0.21 0.57
Cancer 1,053,491 Disease Target BMPR1A 279 63 0.00 -0.88 0.23 0.57
Cancer 1,053,491 Disease Target Glutathione S-Transferase Theta-1 70 22 0.00 -0.83 0.31 0.57
Cancer 1,053,491 Disease Target CAPG 85 25 0.00 -0.84 0.29 0.57
Cancer 1,053,491 Disease Target Prostaglandin Reductase 1 8 4 0.00 -0.71 0.50 0.57
Cancer 1,053,491 Disease Target Beta-Tubulin 4,870 513 0.01 -0.95 0.11 0.57
Cancer 1,053,491 Disease Target Chorionic Gonadotropin beta 936 141 0.00 -0.92 0.15 0.56
Cancer 1,053,491 Disease Target ETS1 539 92 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target bFGF 9,327 821 0.01 -0.95 0.09 0.56
Cancer 1,053,491 Disease Target CA 50 1,293 178 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target CCN5 57 16 0.00 -0.85 0.28 0.56
Cancer 1,053,491 Disease Target BRSK1 20 7 0.00 -0.81 0.35 0.56
Cancer 1,053,491 Disease Target ANGPTL4 289 55 0.00 -0.90 0.19 0.56
Cancer 1,053,491 Disease Target Retinoic Acid Receptor Alpha 1,068 149 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target Alpha-1 AntiChymotrypsin 1,460 188 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Target ERK2 3,287 347 0.01 -0.95 0.11 0.56
Cancer 1,053,491 Disease Target Udp-Glucuronosyltransferase 2,219 250 0.01 -0.94 0.11 0.56
Cancer 1,053,491 Disease Target CCL21 808 113 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target EPHB3 118 25 0.00 -0.89 0.21 0.56
Cancer 1,053,491 Disease Target Buserelin 1,249 157 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Target Glutathione Peroxidase 2 67 16 0.00 -0.87 0.24 0.56
Cancer 1,053,491 Disease Target EPHA3 140 28 0.00 -0.89 0.20 0.56
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56
Cancer 1,053,491 Disease Target Adp/Atp Translocase 3 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Target Steroid 5-Alpha-Reductase 293 49 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Collapsin Response Mediator Protein-1 30 8 0.00 -0.86 0.27 0.56
Cancer 1,053,491 Disease Target beta-Cellulin 17 5 0.00 -0.84 0.29 0.56
Cancer 1,053,491 Disease Target Glutathione Peroxidase 3 132 25 0.00 -0.90 0.19 0.56
Cancer 1,053,491 Disease Target Endothelin A Receptor 722 94 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Target BMX 185 32 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target CCL2 3,560 327 0.01 -0.95 0.09 0.56
Cancer 1,053,491 Disease Target ACVR1B 23 6 0.00 -0.86 0.26 0.56
Cancer 1,053,491 Disease Target CCL18 256 40 0.00 -0.92 0.16 0.56
Cancer 1,053,491 Disease Target CXCL3 145 25 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target DNA-damage-inducible transcript 3 30 7 0.00 -0.88 0.23 0.56
Cancer 1,053,491 Disease Target Glutathione S-Transferase A3 15 4 0.00 -0.86 0.27 0.56
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Target Glutathione S-Transferase A1 111 19 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Peroxisome Proliferator-Activated Receptor Delta 355 47 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Target DAPK2 27 6 0.00 -0.88 0.22 0.56
Cancer 1,053,491 Disease Target CCL5 2,002 186 0.00 -0.95 0.09 0.56
Cancer 1,053,491 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target CXCL14/BRAK 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target ENO2 87 15 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target CD146 729 79 0.00 -0.94 0.11 0.55
Cancer 1,053,491 Disease Target EG-VEGF 63 11 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target Dihydrofolate Reductase 5,563 401 0.01 -0.96 0.07 0.55
Cancer 1,053,491 Disease Target Collagenase 3 367 45 0.00 -0.94 0.12 0.55
Cancer 1,053,491 Disease Target EPHB1 137 20 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target ACY1 51 9 0.00 -0.91 0.18 0.55
Cancer 1,053,491 Disease Target B2M 677 72 0.00 -0.95 0.11 0.55
Cancer 1,053,491 Disease Target D-Dimer 6,185 428 0.01 -0.96 0.07 0.55
Cancer 1,053,491 Disease Target Beta-R1 38 7 0.00 -0.90 0.18 0.55
Cancer 1,053,491 Disease Target Signal Transducer And Activator Of Transcription 5b 82 13 0.00 -0.92 0.16 0.55